Malin Corporation | MLC - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
ALKERMES USD 1.82B 85.86M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Eurofins Scientific SE EUR 3.54B 114.8M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.5B 343M 2025-12
Lonza CHF 9.13B 513M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Moderna USD 8.65B 680M 2025-12
Organon & Co USD 906M 173M 2025-09
Ovoca Bio EUR 1.26M 7.41M 2025-06
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12